1. Home
  2. RMTI vs FORA Comparison

RMTI vs FORA Comparison

Compare RMTI & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rockwell Medical Inc.

RMTI

Rockwell Medical Inc.

N/A

Current Price

$0.89

Market Cap

34.0M

Sector

Health Care

ML Signal

N/A

Logo Forian Inc.

FORA

Forian Inc.

N/A

Current Price

$2.09

Market Cap

66.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
RMTI
FORA
Founded
1994
2014
Country
United States
United States
Employees
300
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
34.0M
66.2M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
RMTI
FORA
Price
$0.89
$2.09
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.50
N/A
AVG Volume (30 Days)
243.0K
14.5K
Earning Date
04-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
91.89
N/A
EPS
N/A
N/A
Revenue
$101,489,000.00
$20,153,263.00
Revenue This Year
N/A
$51.82
Revenue Next Year
$8.14
$7.24
P/E Ratio
N/A
N/A
Revenue Growth
21.38
N/A
52 Week Low
$0.78
$1.64
52 Week High
$2.10
$2.71

Technical Indicators

Market Signals
Indicator
RMTI
FORA
Relative Strength Index (RSI) 42.69 41.53
Support Level $0.80 $2.05
Resistance Level $1.02 $2.12
Average True Range (ATR) 0.05 0.02
MACD -0.00 -0.00
Stochastic Oscillator 35.69 10.00

Price Performance

Historical Comparison
RMTI
FORA

About RMTI Rockwell Medical Inc.

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: